期刊
BRITISH JOURNAL OF PHARMACOLOGY
卷 153, 期 -, 页码 S27-S34出版社
WILEY
DOI: 10.1038/sj.bjp.0707524
关键词
A(2A) adenosine; receptor; cyclic AMP; inflammation; immunosuppression
资金
- Biotechnology and Biological Sciences Research Council Funding Source: Medline
The purine nucleoside adenosine has been described as a 'retaliatory metabolite' by virtue of its ability to function in an autocrine manner to modify the activity of a range of cell types following its extracellular accumulation during cell stress or injury. These effects are largely protective and are triggered by the binding of adenosine to any of four G-protein-coupled adenosine receptors. Most of the anti-inflammatory effects of adenosine have been assigned to the adenosine A(2A) receptor subtype, which is expressed in many immune and inflammatory cells. In this brief article, we will outline the growing evidence to support the hypothesis that the development of agonists selective for the A2A receptor is an effective strategy for suppressing the exaggerated inflammatory responses associated with many diseases by virtue of the receptor's ability to inhibit multiple pro-inflammatory signalling cascades.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据